Reference - PMID:38525852 - Recent Advances on Small-Molecule Inhibitors of Lipocalin-like Proteins.
Reference summary
- PubMed ID
- PMID:38525852
- Title
- Recent Advances on Small-Molecule Inhibitors of Lipocalin-like Proteins.
- Authors
- Chen S, Pan Z, Liu M, Guo L, Jiang X, He G
- Citation
- J Med Chem 2024 Apr 11;67(7):5144-5167
- Publication year
- 2024
- Abstract
- Lipid transfer proteins (LTPs) are crucial players in nonvesicular lipid trafficking. LTPs sharing a lipocalin lipid transfer domain (lipocalin-like proteins) have a wide range of biological functions, such as regulating immune responses and cell proliferation, differentiation, and death as well as participating in the pathogenesis of inflammatory, metabolic, and neurological disorders and cancer. Therefore, the development of small-molecule inhibitors targeting these LTPs is important and has potential clinical applications. Herein, we summarize the structure and function of lipocalin-like proteins, mainly including retinol-binding proteins, lipocalins, and fatty acid-binding proteins and discuss the recent advances on small-molecule inhibitors for these protein families and their applications in disease treatment. The findings of our Perspective can provide guidance for the development of inhibitors of these LTPs and highlight the challenges that might be faced during the procedures.
